Dosimetry in a patient with peritoneal dialysis treated with [177Lu]Lu-PSMA-617
Nuklearmedizin - NuclearMedicine · 01.06.2024 · 63 (03) · 224-226
DOI: 10.1055/a-2224-9536 ↗Kurz gefasst
Fallbericht in der Zeitschrift Nuklearmedizin - NuclearMedicine, erschienen am 01.06.2024. Verfasst von Kathrin Glass und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, University Hospital Halle, Halle, Germany. Hauptthemen laut MEDLINE: Dipeptides, Lutetium, Heterocyclic Compounds, 1-Ring, Peritoneal Dialysis. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, University Hospital Halle, Halle, Germany.
- Ambulatory Healthcare Center Nuclear Medicine and Hybrid Imaging Saalekreis, Merseburg, Germany.
Zitieren
APA
Glass, K., Hering, A. H., & Heinzel, A. (2024). Dosimetry in a patient with peritoneal dialysis treated with [177Lu]Lu-PSMA-617. Nuklearmedizin - NuclearMedicine, 63(03), 224-226. https://doi.org/10.1055/a-2224-9536
Vancouver
Glass K, Hering AH, Heinzel A. Dosimetry in a patient with peritoneal dialysis treated with [177Lu]Lu-PSMA-617. Nuklearmedizin - NuclearMedicine. 2024;63(03):224-226. doi:10.1055/a-2224-9536
BibTeX
@article{Glass2024,
author = {Glass, Kathrin and Hering, Andreas Hendrik and Heinzel, Alexander},
title = {Dosimetry in a patient with peritoneal dialysis treated with [177Lu]Lu-PSMA-617},
journal = {Nuklearmedizin - NuclearMedicine},
year = {2024},
volume = {63},
number = {03},
pages = {224--226},
doi = {10.1055/a-2224-9536}
}
EUVIMED